{
  "question": "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) loss of protein dimerization and wild-type phenotype\nC) protein aggregation and loss-of-function phenotype\nD) change of protein conformation and gain-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>",
  "response_list": [
    "This question asks for the most likely molecular phenotype of a dominant-negative mutation (Y) located in the dimerization domain of a transcription factor.\n\nHere's a step-by-step breakdown of the concepts involved:\n\n1.  **Transcription Factor Function:** The wild-type protein needs to form a dimer to become active. A single subunit (monomer) is inactive. The active dimer then enters the nucleus to regulate gene transcription.\n\n2.  **Dominant-Negative Mutation:** This type of mutation produces an altered protein that not only is non-functional itself but also interferes with the function of the wild-type protein produced from the normal allele in a heterozygote. This is common in proteins that need to form complexes, like dimers or tetramers.\n\n3.  **Mutation Y in the Dimerization Domain:** Since the mutation is in the dimerization domain and acts as a dominant-negative, the mutant protein (Y) must still be able to dimerize with the wild-type protein (WT). If it couldn't dimerize at all, it wouldn't be able to interfere with the WT protein, and the mutation would likely be recessive (as seen with mutation X).\n\n4.  **Molecular Mechanism:** In a heterozygous cell (WT/Y), three types of dimers can potentially form:\n    *   **WT-WT dimer:** This is a fully functional, active transcription factor.\n    *   **Y-Y dimer:** This dimer, containing two mutant subunits, is non-functional.\n    *   **WT-Y dimer:** This is a heterodimer containing one wild-type and one mutant subunit. Because the Y mutation is dominant-negative, this heterodimer is also non-functional. The mutant Y subunit effectively \"poisons\" the wild-type subunit it pairs with.\n\n5.  **Evaluating the Options:**\n    *   **A) protein degradation and loss-of-function of the wild-type allele:** This is the most likely scenario. The formation of non-functional WT-Y heterodimers inactivates the wild-type protein subunit. Such aberrant or malformed protein complexes are often recognized by the cell's quality control machinery (e.g., the ubiquitin-proteasome system) and targeted for degradation. This degradation would remove both the mutant and the wild-type subunits that are trapped in the non-functional dimer, further reducing the amount of available functional protein and amplifying the loss-of-function effect. The phrase \"loss-of-function of the wild-type allele\" accurately describes the outcome where the protein product from the normal allele is rendered non-functional.\n    *   **B) loss of protein dimerization and wild-type phenotype:** This is incorrect. A dominant-negative effect requires the mutant protein to interact (dimerize) with the wild-type protein. Also, a dominant-negative mutation results in a mutant phenotype, not a wild-type one.\n    *   **C) protein aggregation and loss-of-function phenotype:** While some missense mutations can lead to protein aggregation, it's a specific mechanism. The classic model for a dominant-negative effect in a dimeric protein is interference via heterodimerization, which may or may not lead to large-scale aggregation. Degradation of the faulty dimer (as in option A) is a more direct and common consequence.\n    *   **D) change of protein conformation and gain-of-function phenotype:** A dominant-negative mutation results in a loss-of-function phenotype, not a gain-of-function.\n\n**Conclusion:** The Y mutant protein dimerizes with the wild-type protein, forming a non-functional complex. This complex inactivates the wild-type protein and is likely targeted for degradation, leading to an overall loss of function.\n\n<<<A>>>"
  ],
  "user_prompt_list": [
    "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) protein degradation and loss-of-function of the wild-type allele\nB) loss of protein dimerization and wild-type phenotype\nC) protein aggregation and loss-of-function phenotype\nD) change of protein conformation and gain-of-function phenotype\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>"
  ],
  "system_message": ""
}